CIAM
STLN

Caitong International Asset Management’s Starling Oncology STLN Stock Holding History

Caitong International Asset Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.1K Sell
11,061
-22,219
-67% -$93.3K 0.01% 673
2026
Q1 		$102K Buy
33,280
+10,814
+48% +$33.2K 0.02% 569
2025
Q4 		$80K Buy
22,466
+19,190
+586% +$71.2K 0.02% 527
2025
Q3 		$11.4K Buy
+3,276
New +$11.2K 0.01% 970

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Caitong International Asset Management's STLN Position: Q2 2026 in Review

Caitong International Asset Management reduced its Starling Oncology (STLN) stake by 67% in Q2 2026, selling an estimated $93.3K and leaving 11,061 shares worth $60.1K. The position accounts for 0.01% of the portfolio, ranked #673.

Caitong International Asset Management first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $102K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Caitong International Asset Management held 11,061 shares of Starling Oncology worth $60.1K as of Q2 2026.
  • Caitong International Asset Management sold 22,219 Starling Oncology shares in Q2 2026, an estimated $93.3K.
  • Starling Oncology made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #673 holding.
  • Caitong International Asset Management first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Starling Oncology position peaked at $102K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.